Sepsis is the body’s life-threatening, imbalanced response to a severe infection. The condition affects 1.7 million people and takes 270,000 lives in the U.S. every year. This year, we face additional risks because of the threat of COVID-19.
COVID-19 Pandemic Presents Opportunities for Formal Integration of Antimicrobial Stewardship & Infection Prevention Programs
A 2018 paper jointly published by three leading infectious disease organizations (APIC, SHEA, and SIDP) stated that infection prevention and control and antibiotic stewardship programs are inextricably linked.
Universal Mass Testing vs. Targeted Testing for COVID-19
By the bioMérieux Connection Editors Although some countries have managed to effectively flatten the curve and curb the spread of COVID-19, new cases in the United States have been on an upward trajectory as phased re-openings occur throughout the country. While vaccines are being developed and tested, elected officials must make critical decisions regarding COVID-19 …
Continue reading “Universal Mass Testing vs. Targeted Testing for COVID-19”
Current & Potential Treatment Options For COVID-19
As cases of COVID-19 are on the rise again in several places in the U.S., the need for effective treatment remains. Many potential COVID-19 treatments that could have an impact on our ability to fight the virus are currently being developed or tested in clinical trials.
World Antimicrobial Awareness Week 2020 Toolkit
Each year, healthcare organizations, schools, governments, companies, and communities around...
COVID-19 and Antimicrobial Resistance: Dual Health Threats
Each year, more than 700,000 people lose their lives to...